Biogen, Inc. (NQ: BIIB )

265.79 USD -0.40 (-0.15%)

Official Closing Price Updated: 7:56 PM EDT, Apr 14, 2021 Add to My Watchlist

Price and Volume

Volume	697,400
Open	267.44
Bid (Size)	264.68 (1)
Ask (Size)	274.49 (1)
Prev. Close	266.19
Today's Range	264.63 - 270.38
52wk Range	223.25 - 363.92
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Biogen to Present Trial Design of Aducanumab EMBARK Re-Dosing Study in Poster Session at 2021 Virtual AAN Annual Meeting on April 17-22, 2021

Today 16:06 EDT

The Road to a 100% Electric Vehicle Fleet

Today 6:00 EDT

Performance

YTD	+9.40%	+9.40%
1 Month	+2.18%	+2.18%
3 Month	-0.33%	-0.33%
6 Month	-8.04%	-8.04%
1 Year	-20.36%	-20.36%

More News

Biogen Announces Two New Nominees for Election to Board of Directors

April 09, 2021

Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint

April 12, 2021

Biogen and Bio-Thera Solutions Announce Commercialization and License Agreement for Proposed Biosimilar Currently in Phase 3 With the Potential to Treat Moderate to Severe Rheumatoid Arthritis

April 08, 2021

The European Commission Grants Marketing Authorization for New Subcutaneous Administration of TYSABRI® (natalizumab) to Treat Relapsing-Remitting Multiple Sclerosis

April 07, 2021

Sage-Biogen Essential Tremor Candidate Hits Primary Endpoint Goal, But 38% Of People Drop Out

April 12, 2021

3 Beaten-Down Biotech Stocks: Can They Recover?

April 13, 2021

Noteworthy Friday Option Activity: JNJ, BIIB, BBY

April 09, 2021

Sage Stock Trips As Analysts Question Longevity Of Biogen-Partnered Drug

April 12, 2021

Week in Review: Sorrento Acquires ACEA in $488 Million Deal between Two San Diego-China Oncology Biopharmas

April 10, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.